Consun Pharmaceutical Group Ltd
HKEX:1681
Consun Pharmaceutical Group Ltd
HKEX:1681
Price:
5.98 HKD
2.22%
Market Closed
Updated:
May 2, 2024
Consun Pharmaceutical Group Ltd
Operating Income
|
Consun Pharmaceutical Group Ltd
Operating Income Peer Comparison
Comparables:
H
3692
600436
600276
000538
C
300765
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Consun Pharmaceutical Group Ltd
HKEX:1681
|
Operating Income
¥885.8m
|
CAGR 3-Years
17%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Income
¥787.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
See Also
What is Consun Pharmaceutical Group Ltd's Operating Income?
Operating Income
885.8m
CNY
885.8m
CNY
Based on the financial report for Dec 31, 2023, Consun Pharmaceutical Group Ltd's Operating Income amounts to 885.8m CNY.
What is Consun Pharmaceutical Group Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
16%
16%
Over the last year, the Operating Income growth was 24%. The average annual Operating Income growth rates for Consun Pharmaceutical Group Ltd have been 17% over the past three years , 6% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
